Living with COVID-19: Celiac Disease, Autoimmunity, and Hyperinflammation

The second webinar in the National Celiac Association (NCA) and the Harvard Medical School Celiac Research Program Spring 2022 “All Things Celiac” series was held on Wednesday, March 23, 2022 at 1pm ET. Speakers presented on selected topics for 60 minutes, followed by 15 minutes for Q&A.

Will the pandemic ever end? And what are the long-term effects (if any) for someone living with celiac disease or another autoimmune disorder? What COVID-19 treatments are safe for people with celiac disease and are all masks safe for people with gluten-related disorders?

Two expert authors and clinicians with decades of experience answered new questions about COVID-19, celiac disease and autoimmunity: Alessio Fasano, MD, Director of the Center for Celiac Research and Treatment at Massachusetts General Hospital in Boston, Massachusetts; and Dr. Steven Plogsted, BS, PharmD, BCNSP, CNSC, FASPEN, Clinical Pharmacy Specialist (retired) at Nationwide Children’s Hospital in Columbus, Ohio.

Lee Graham, executive director of the NCA, introduced the webinar, and Dan Leffler, MD, MS, a gastroenterologist and co-founder of the Celiac Center at Beth Israel Deaconess Medical Center, moderated the session. A Q&A session followed the presentations.

Please note: This was an educational webinar, and no information was intended for diagnosis or treatment of any medical condition. Please seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.